Enhancing effect of phenobarbital on the development of enzyme-altered islands and hepatocellular carcinomas initiated by 3'-methyl-4-(dimethylamino) azobenzene or diethylnitrosamine.
D000251:Adenosine Triphosphatases / Q000032:analysis; D000818:Animals; D004052:Diethylnitrosamine; D004357:Drug Synergism; D008099:Liver / Q000201:enzymology* / Q000473:pathology; D008114:Liver Neoplasms, Experimental / Q000139:chemically induced* / Q000201:enzymology; D008297:Male; D008749:Methyldimethylaminoazobenzene; D009602:Nitrosamines; D010634:Phenobarbital; D011230:Precancerous Conditions / Q000139:chemically induced* / Q000201:enzymology / Q000473:pathology; D051381:Rats; D004124:p-Dimethylaminoazobenzene / Q000031:analogs & derivatives
D009602:Nitrosamines; D004052:Diethylnitrosamine; D008749:Methyldimethylaminoazobenzene; D004124:p-Dimethylaminoazobenzene; D000251:Adenosine Triphosphatases; D010634:Phenobarbital